• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 204-218 of 415 results

1107 Exhibit: Reply Declaration of Igor Gonda, PhD

Document IPR2021-00406, No. 1107-199 Exhibit - Reply Declaration of Igor Gonda, PhD (P.T.A.B. Feb. 10, 2022)

cite Cite Document

1104 Exhibit: Sulica, R and Poon, M, ���Medical therapeutics for pulmonary arterial ...

Document IPR2021-00406, No. 1104-196 Exhibit - Sulica, R and Poon, M, ���Medical therapeutics for pulmonary arterial hypertension from basic science and clinical trial design to evidence based medicine...

cite Cite Document

1100 Exhibit: Ventavis EU Summary of Product Characteristics

Document IPR2021-00406, No. 1100-193 Exhibit - Ventavis EU Summary of Product Characteristics (P.T.A.B. Feb. 10, 2022)

cite Cite Document

1095 Exhibit: Voswinckel JAHA, Stanford

Document IPR2021-00406, No. 1095-188 Exhibit - Voswinckel JAHA, Stanford (P.T.A.B. Feb. 10, 2022)

cite Cite Document

3003 Exhibit: Ex 3003

Document IPR2021-00406, No. 3003-241 Exhibit - Ex 3003 (P.T.A.B. Aug. 22, 2022)

cite Cite Document

1009 Exhibit: Voswinckel, et al, ¿¿¿Clinical Observations¿¿¿ on ¿¿¿Inhaled Treprostinil ...

Document IPR2021-00406, No. 1009-9 Exhibit - Voswinckel, et al, ¿¿¿Clinical Observations¿¿¿ on ¿¿¿Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension,¿¿¿ ¿¿¿Letters¿¿¿ Section of the...

cite Cite Document

1070 Exhibit: Beasley, R, et al, ¿¿¿Preservatives in Nebulizer Solutions Risks withou...

Document IPR2021-00406, No. 1070-67 Exhibit - Beasley, R, et al, ¿¿¿Preservatives in Nebulizer Solutions Risks without Benefit,¿¿¿ Pharmacotherapy, 181130 39 1998 (P.T.A.B. Jan. 7, 2021)

cite Cite Document

1057 Exhibit: October 24, 2005 Press Release, ¿¿¿Aradigm Corporation And United...

Document IPR2021-00406, No. 1057-55 Exhibit - October 24, 2005 Press Release, ¿¿¿Aradigm Corporation And United Therapeutics Corporation Sign Development and Commercialization Agreement Targ...

cite Cite Document

1065 Exhibit: Olschewski, H, et al, ¿¿¿Inhaled Iloprost for Several Pulmonary Hypert...

Document IPR2021-00406, No. 1065-62 Exhibit - Olschewski, H, et al, ¿¿¿Inhaled Iloprost for Several Pulmonary Hypertension,¿¿¿ N Engl J Med, 3475322 29 2002 (P.T.A.B. Jan. 7, 2021)

cite Cite Document

1018 Exhibit: Remodulin¿¿ 2004 Label

Document IPR2021-00406, No. 1018-18 Exhibit - Remodulin¿¿ 2004 Label (P.T.A.B. Jan. 7, 2021)

cite Cite Document

1076 Exhibit: October 23, 2017 Press Release, ¿¿¿United Therapeutics Announces ...

Document IPR2021-00406, No. 1076-72 Exhibit - October 23, 2017 Press Release, ¿¿¿United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso¿¿ Inhalation System¿¿¿ (P...

cite Cite Document

1047 Exhibit: Hoeper, MM, et al, ¿¿¿Long Term Treatment of Primary Pulmonary Hyp...

Document IPR2021-00406, No. 1047-45 Exhibit - Hoeper, MM, et al, ¿¿¿Long Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue,¿¿¿ N Engl J Med, 342186...

cite Cite Document

1023 Exhibit: Olschewski, H, et al, ¿¿¿Inhaled Prostacyclin and Iloprost in Severe Pu...

Document IPR2021-00406, No. 1023-23 Exhibit - Olschewski, H, et al, ¿¿¿Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis,¿¿¿ American Journal of Respiratory...

cite Cite Document

1042 Exhibit: January 27, 2020 Press Release, ¿¿¿Liquidia Submits New Drug Applic...

Document IPR2021-00406, No. 1042-41 Exhibit - January 27, 2020 Press Release, ¿¿¿Liquidia Submits New Drug Application for LIQ861 Treprostinil Inhalation Powder to US Food And Drug Administration f...

cite Cite Document

1019 Exhibit: Stein, SW, et al, ¿¿¿The History of Therapeutic Aerosols A Chronologic...

Document IPR2021-00406, No. 1019-19 Exhibit - Stein, SW, et al, ¿¿¿The History of Therapeutic Aerosols A Chronological Review,¿¿¿ Journal of Aerosol Medicine and Pulmonary Drug Delivery, 30120 41 201...

cite Cite Document
<< 1 2 3 4 5 ... 14 15 16 17 18 ... >>